carbapenems has been researched along with Pneumococcal Infections in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akagi, M; Fukuda, S; Higuchi, T; Hikita, Y; Jikimoto, T; Kamisako, T; Kida, K; Kita, M; Kofuku, T; Komatsu, M; Maede, T; Moro, K; Nakai, I; Nakamura, T; Nishi, I; Nishio, H; Ono, T; Oohama, M; Orita, T; Satoh, K; Shimakawa, K; Sueyoshi, N; Tanaka, Y; Tobe, T; Toda, H; Toyokawa, M; Wada, Y; Yamasaki, K | 1 |
| Aguilar, L; Biek, D; Fenoll, A; Giménez, MJ; Granizo, JJ; Robledo, O; Tarragó, D | 1 |
| Choi, SH; Chung, JW; Kim, MN; Kim, SH; Kim, YS; Lee, SO; Sung, H; Woo, JH | 1 |
| Chiba, N; Morozumi, M; Ubukata, K | 1 |
| Sugita, R | 1 |
| Billal, DS; Fujihara, K; Fukushima, T; Hotomi, M; Itahashi, K; Nagura, J; Shimada, J; Suzumoto, M; Yamanaka, N; Yamauchi, K | 1 |
| Choi, SH; Jeon, MH; Jeong, JY; Jun, JB; Kim, MN; Kim, SC; Kim, YS; Kwon, HH; Lee, SR; Park, SJ; Woo, JH | 1 |
| Mikamo, H; Tanaka, K; Watanabe, K | 1 |
| Edwards, JR; Nairn, K; Shepherd, GL | 1 |
| Ishii, Y; Miyazaki, S; Ohno, A; Tsuji, M; Yamaguchi, K | 1 |
| Kaku, M | 1 |
| Verbist, L; Verhaegen, J | 1 |
| Bradley, JS; Edwards, JR; Klugman, KP | 1 |
| Tateda, K; Yamaguchi, K | 1 |
2 review(s) available for carbapenems and Pneumococcal Infections
| Article | Year |
|---|---|
[Emerging and drug-resistant infectious diseases--penicillin resistant Streptococcus pneumoniae infections].
Topics: 4-Quinolones; Anti-Infective Agents; Carbapenems; Cross Infection; Humans; Penicillin Resistance; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae | 1997 |
[Penicillin-resistant Streptococcus pneumoniae infections: current trends in epidemiology and antibiotic chemotherapy].
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Disease Models, Animal; Humans; Japan; Mice; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin | 2000 |
12 other study(ies) available for carbapenems and Pneumococcal Infections
| Article | Year |
|---|---|
Laboratory surveillance of antimicrobial resistance and multidrug resistance among Streptococcus pneumoniae isolated in the Kinki region of Japan, 2001-2015.
Topics: Adult; Carbapenems; Cephalosporins; Child; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Heptavalent Pneumococcal Conjugate Vaccine; Humans; Japan; Macrolides; Penicillins; Pneumococcal Infections; Retrospective Studies; Streptococcus pneumoniae | 2018 |
In vitro activity of ME1036 versus other beta-lactams against penicillin-resistant Streptococcus pneumoniae serotypes exhibiting higher amoxicillin than penicillin MIC.
Topics: Amoxicillin; Anti-Bacterial Agents; Carbapenems; Humans; Microbial Sensitivity Tests; Penicillins; Pneumococcal Infections; Spain; Streptococcus pneumoniae | 2008 |
Impact of penicillin nonsusceptibility on clinical outcomes of patients with nonmeningeal Streptococcus pneumoniae bacteremia in the era of the 2008 clinical and laboratory standards institute penicillin breakpoints.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Child; Child, Preschool; Female; Humans; Infant; Length of Stay; Male; Middle Aged; Penicillin Resistance; Penicillins; Pneumococcal Infections; Retrospective Studies; Streptococcus pneumoniae; Survival Rate; Treatment Outcome; Vancomycin | 2012 |
[Morphological changes in penicillin-resistant Streptococcus pneumoniae and beta-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae after exposure to oral antibacterial agents].
Topics: Amoxicillin; Ampicillin Resistance; Anti-Bacterial Agents; Bacteriolysis; beta-Lactamases; Carbapenems; Cephalosporins; Child; Dose-Response Relationship, Drug; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Microscopy, Phase-Contrast; Naphthyridines; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Time Factors | 2012 |
Good transfer of tebipenem into middle ear effusion conduces to the favorable clinical outcomes of tebipenem pivoxil in pediatric patients with acute otitis media.
Topics: Anti-Bacterial Agents; Carbapenems; Child, Preschool; Cohort Studies; Exudates and Transudates; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Otitis Media with Effusion; Pneumococcal Infections; Streptococcus pneumoniae; Treatment Outcome | 2013 |
Efficacy of a novel oral carbapenem, tebipenem pivoxil (TBM-PI), against experimental otitis media caused by penicillin resistant Streptococcus pneumoniae in chinchilla.
Topics: Administration, Oral; Amoxicillin; Animals; Anti-Bacterial Agents; Carbapenems; Chinchilla; Male; Models, Animal; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 2007 |
Comparative in vitro activities of carbapenem antimicrobial agents against 264 penicillin-resistant Streptococcus pneumoniae isolates from Korea.
Topics: Anti-Bacterial Agents; Carbapenems; Humans; Korea; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae | 2007 |
[Efficacy of injectable carbapenems for respiratory infections caused by Streptococcus pneumoniae and Haemophilus influenzae with Monte Carlo simulation].
Topics: Carbapenems; Dose-Response Relationship, Drug; Haemophilus Infections; Haemophilus influenzae; Immunocompromised Host; Injections; Monte Carlo Method; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 2007 |
Efficacy of meropenem in experimental meningitis.
Topics: Ampicillin; Animals; Carbapenems; Ceftazidime; Ceftriaxone; Cephalosporins; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Drug Evaluation; Drug Resistance, Microbial; Escherichia coli Infections; Gentamicins; Guinea Pigs; Haemophilus Infections; Haemophilus influenzae; Listeriosis; Meningitis, Bacterial; Meropenem; Neisseria meningitidis; Penicillin G; Pneumococcal Infections; Thienamycins | 1995 |
In vitro and in vivo antibacterial activities of S-4661, a new carbapenem.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Disease Models, Animal; Doripenem; Enterobacteriaceae; Haemophilus influenzae; Male; Mice; Microbial Sensitivity Tests; Moraxella; Penicillin Resistance; Pneumococcal Infections | 1998 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae | 1998 |
Current MIC breakpoints may understate the potential efficacies of carbapenems for treatment of patients with infections caused by strains of Streptococcus pneumoniae that are resistant or of intermediate susceptibility to penicillin.
Topics: Carbapenems; Humans; Microbial Sensitivity Tests; Outcome Assessment, Health Care; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 1998 |